在癌症和代谢障碍中FOXK2的新兴作用
Xiaoke Xing1, Xiangyong Que1, Sihao Zheng1
1Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
Frontiers in oncology
|May 14, 2024
概括
叉头盒K2 (FOXK2) 影响细胞功能并影响各种癌症. 它作为瘤基因或瘤抑制剂的双重作用为向癌症治疗提供了潜在的潜力.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 遗传学 是一个遗传学.
背景情况:
- 叉头盒K2 (FOXK2) 转录因子对于细胞过程如增殖,分化和DNA修复至关重要.
- FOXK2在癌症中表现出上下文依赖的作用,在某些癌症中充当瘤基因,在其他癌症中充当瘤抑制剂.
研究的目的:
- 审查了解FOXK2监管及其下游目标的最新进展.
- 突出FOXK2失调在癌症发展中的作用.
- 探索向FOXK2在癌症治疗中的治疗潜力.
主要方法:
- 关于FOXK2.2最近研究的文献综述.
- 对FOXK2的监管机制和下游目标的分析.
- 检查FOXK2在各种癌症类型中的作用.
主要成果:
- FOXK2参与关键的细胞功能,包括核酸生物合成和对DNA损伤的反应.
- 在结肠直肠癌和肝癌中,FOXK2充当瘤基因,但在乳腺癌,宫癌和非小细胞肺癌 (NSCLC) 中充当瘤抑制剂.
- 失调FOXK2显著影响癌症病因学.
结论:
- 了解FOXK2的复杂作用对于癌症研究至关重要.
- 向FOXK2为新型癌症疗法提供了一个有希望的途径.
- 对FOXK2调控网络和治疗策略的进一步研究是有必要的.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.9K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Regulation of Metabolism
9.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
